Staying One Step Ahead of Government Censors

Before Sept. 11, academic research managers could easily run labs without running afoul of export controls. Talking to foreign-born students, chatting with overseas colleagues, and publishing the results of research presented few regulatory obstacles. But managers now may be required to reassess their research styles when it comes to such diurnal tasks. Regulations under consideration in Washington, DC, could narrow exemptions that allow free international information exchanges, experts on US s

Written byPeg Brickley
| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

Regulations under consideration in Washington, DC, could narrow exemptions that allow free international information exchanges, experts on US science policy warn. "We face a real problem in terrorism that uses low technologies against us," says Eugene B. Skolnikoff, professor of political science at Massachusetts Institute of Technology, who writes on science policy. "At the same time, I have a sense that there is a different attitude ... within some [government] agencies, a sense of panic, or sense that we are at war. There is a level of overreaction that is likely to damage the very security that we're trying to protect."

The White House Office of Science and Technology Policy is participating in a redrafting of the directive, with a view toward safeguarding scientific freedom, says Victor Teplitz of OSTP. "There's a genuine understanding that open dialogue to the maximum extent is very beneficial," Teplitz says. "There's a reluctance to ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies